Clinical Trials Logo

Spondylolysis clinical trials

View clinical trials related to Spondylolysis.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05846477 Recruiting - Clinical trials for Degenerative Disc Disease

MySpine MC Versus MySpine Standard

MC vs STD
Start date: February 4, 2021
Phase:
Study type: Observational

This research project compares the clinical performance of the cortical bone trajectory CBT insertion technique with the current clinical Gold standard, the Pedicle screw insertion technique. Both techniques are performed by aid of MySpine patient-specific guide systems.

NCT ID: NCT05505981 Recruiting - Lumbar Spondylosis Clinical Trials

An Immediate Functional Progression Program for Adolescent Athletes With Spondylolysis

Start date: August 22, 2022
Phase: N/A
Study type: Interventional

Spondylolysis, a stress fracture in the pars interarticularis of a lumbar vertebra, is the most common identifiable cause of low back pain (LBP) in adolescent athletes, occurring in 14-30% of athletes who experience LBP. Spondylolysis can cause significant pain and disability and months of exclusion from sports or an active lifestyle. Standard care of spondylolysis in adolescent athletes is primarily based on expert opinion, with dramatic variations in clinical practice, including restrictive bracing, extended rest periods before the intervention, long durations out of sport and activity, and suboptimal long-term clinical outcomes. As the next step towards our research goal, the overall objective of this pilot study is to perform a pilot randomized controlled trial to assess a novel rehabilitation strategy, the immediate functional progression program (IFPP), for treating active spondylolysis in adolescent athletes. Participants randomized to the IFPP group will begin physical therapy immediately (<1 week) after diagnosis. In contrast, those in the standard care group (control) will not start physical therapy until their pain has resolved. Aim 1 will evaluate the effects of the IFPP on outcomes (Function, Pain, Quality of Life, and Edema on MRI) among adolescent athletes with an active spondylolysis. Aim 2 will assess the feasibility of performing a full randomized trial using the novel IFPP to treat athletes ages 10-19 with an active spondylolysis. Aim 3 will compare the tolerability of the IFPP to standard care. This pilot study will lay the necessary groundwork to perform a larger hypothesis-driven randomized controlled trial.

NCT ID: NCT02854904 Recruiting - Spondylolisthesis Clinical Trials

Immune Effect of Dexmedetomidine in Patients Undergoing to Spinal Fusion

eMUNODEX
Start date: August 2016
Phase: Phase 2/Phase 3
Study type: Interventional

Alpha-agonist in anesthesia display immunomodulatory effect in addition to antiadrenergic control. This effect of the immune system can be a key to a better perioperative safety and quality. The association of dexmedetomidine at general anesthesia adds up organic protection and inflammatory control to a surgery trauma owing to antinociception and immunomodulatory effect. The aim this study is evaluate if the association of dexmedetomidine at general anesthesia standing effective immunomodulatory control to trauma and improve changes at outcomes in patients undergoing to spinal fusion.